Report Overview
The Global Spirulina Protein Market size is expected to be worth around USD 1.4 Billion by 2035, from USD 0.8 Billion in 2025, growing at a CAGR of 5.6% during the forecast period from 2026 to 2035. In 2025, North America held a dominant market position, capturing more than a 34.78% share, holding USD 0.2 Billion revenue.
Spirulina protein is gaining industrial importance as a nutrient-rich alternative protein ingredient derived from blue-green cyanobacteria, mainly Arthrospira platensis and Arthrospira maxima. It is increasingly used in food and beverages, dietary supplements, sports nutrition, animal feed, aquaculture and functional food formulations. Its commercial value comes from its high protein concentration, essential amino acid content, vitamins, minerals and natural pigments. According to the Food and Agriculture Organization (FAO), spirulina has considerable potential as a protein source for human consumption and animal nutrition.
- The biomass is commonly cultivated in open raceway ponds and closed photobioreactor systems. According to FAO’s Feedipedia database, dried spirulina contains an average of 63.8% crude protein on a dry-matter basis, with reported values ranging from 54.2% to 72.6%. This high concentration makes it attractive for manufacturers seeking concentrated protein ingredients. The FAO Feedipedia nutritional database provides these composition figures.
The industrial scenario is supported by growing investments in algae cultivation infrastructure and biotechnology. In April 2025, Japan-based DIC Corporation announced the commencement of operations at a new edible algae cultivation facility operated by its US subsidiary, Earthrise Nutritionals, in California. The company reported an investment of approximately JPY 1.2 billion in the facility, which began operations in March 2025.
The development reflects increasing investment in controlled cultivation, food safety and sustainable algae production. Further, the Investment and Development Agency of Latvia reported in July 2025 that SpirulinaNord invested more than EUR 1 million in a new production facility, supported by EUR 383,900 in European Maritime, Fisheries and Aquaculture Fund co-financing. Its first production expansion increased cultivation capacity sixfold, from 4 cubic metres to 24 cubic metres.
Key Takeaways
- Spirulina Protein Market size is expected to be worth around USD 1.4 Billion by 2035, from USD 0.8 Billion in 2025, growing at a CAGR of 5.6%.
- Tablets & Capsules held a dominant market position, capturing more than a 30.23% share.
- Dietary Supplements held a dominant market position, capturing more than a 38.56% share
- North America dominated the Spirulina Protein Market, accounting for 34.78% of the global market, valued at USD 0.2 billion.
By Form Analysis
Tablets & Capsules maintain demand due to convenient consumption, easy dosage control and growing use in nutritional supplements.
In 2025, “Tablets & Capsules” held a dominant market position, capturing more than a 30.23% share of the Spirulina Protein Market. This segment benefits from the convenience of carrying, storing and consuming spirulina protein in a pre-measured format. Tablets and capsules are widely used in dietary supplements, wellness products and daily nutritional formulations. Their popularity is supported by consumers seeking convenient protein supplementation without the need to prepare shakes or mix powders into beverages.
In 2025, demand was supported by the wider availability of plant-based nutritional supplements and the growing use of algae-derived ingredients in health-focused product portfolios. The United States Food and Drug Administration (FDA) recognizes tablets and capsules as established dietary supplement formats and requires appropriate Supplement Facts labelling. This regulatory framework supports transparent product information and ingredient declaration.
Powder is an important product form in the Spirulina Protein Market because it can be easily incorporated into smoothies, protein drinks, nutritional powders, bakery products and functional food formulations. In 2025, demand for spirulina protein powder was supported by increasing interest in plant-based nutrition and the use of algae-derived ingredients in protein-enriched products.
According to a European Commission Joint Research Centre (JRC) technical production inventory, a modelled spirulina powder production process recorded an output of 6,270 kg of powder at 7% moisture content. The inventory also reported 18,953 MJ of electricity consumption during harvesting, highlighting the importance of efficient harvesting and processing technologies in commercial production.
By Application Analysis
Dietary Supplements lead demand through growing consumer interest in convenient nutrition and algae-based protein products.
In 2025, “Dietary Supplements” held a dominant market position, capturing more than a 38.56% share of the Spirulina Protein Market. The segment benefits from the increasing use of spirulina protein in nutritional tablets, capsules, powders and health-focused formulations. Spirulina is valued for its naturally high protein content and nutritional composition, making it suitable for manufacturers developing plant-based dietary supplements.
Supplement producers are increasingly incorporating spirulina into products designed for general wellness, nutritional support and active lifestyles. According to the United States Department of Agriculture (USDA), the FoodData Central database provides nutritional composition information for spirulina, supporting its use as a recognized food ingredient in nutritional product development.
Animal Feed & Aquaculture represent an important application area for spirulina protein due to its nutritional value and potential to partially replace conventional protein ingredients in feed formulations. Spirulina is used in fish, shrimp, poultry and other animal feed products to improve nutritional composition and support animal growth. Its protein content makes it attractive to feed manufacturers seeking alternative ingredients for livestock and aquaculture nutrition.
According to the Food and Agriculture Organization (FAO), spirulina meal can replace up to 50% of fishmeal in certain silver seabream diets without adversely affecting growth. The FAO also reported that spirulina supplementation at 5% to 20% improved growth, survival and feed utilization in giant freshwater prawns. These findings support its potential as a functional feed ingredient. In 2025, increasing interest in alternative feed proteins and sustainable aquaculture nutrition continued to create opportunities for spirulina-based formulations.
Key Market Segments
By Form
- Powder
- Spray-Dried Powder
- Freeze-Dried Powder
- Tablets & Capsules
- Tablets
- Capsules (Hard-Shell & Softgels)
- Liquid
- Aqueous Suspensions
- Ready-to-Mix Liquid Blends
- Granules
- Others
- Others
By Application
- Dietary Supplements
- Standalone Spirulina Supplements
- Blended Superfood & Greens Supplements
- Functional Food & Beverages
- Protein Bars & Snack Foods
- Smoothies & Ready-to-Drink Beverages
- Breakfast Cereals & Bakery Products
- Meal Replacement & Weight Management Products
- Animal Feed & Aquaculture
- Poultry Feed
- Aquaculture Feed (Salmon, Shrimp, Tilapia)
- Pet Food & Companion Animal Nutrition
- Swine & Cattle Feed
- Pharmaceuticals
- Anti-Inflammatory & Antioxidant Formulations
- Immunomodulatory & Clinical Nutrition Applications
- Cosmetics & Personal Care
- Skincare (Creams, Serums, Masks)
- Haircare Products
- Others
Driver Analysis
Daily Nutritional Supplementation
Established powder and tablet formats create repeat ingredient demand by positioning spirulina as a small daily nutritional addition rather than requiring consumers to replace an entire meal or protein source. Nutrex Hawaii currently specifies a 3-g serving providing 2 g protein and offers both powders and tablets; its 1,000-mg tablet format requires three tablets per serving, while the 500-mg format requires six. A 16-oz powder container lists 151 servings, illustrating a replenishment model measured in months rather than individual beverage occasions.
In an illustrative cohort of one million incremental consumers purchasing 3 g daily for 250 consumption days annually, ingredient demand reaches 750 tonnes. At an assumed USD 12/kg bulk realization, gross manufacturer revenue is USD 9 million; if 40% replaces existing in-scope spirulina purchases, net category expansion falls to USD 5.4 million. At a modeled 60% protein content, the dose supplies 1.8 g protein daily, demonstrating why the purchasing proposition combines multiple nutritional attributes rather than protein quantity alone.
Suppliers capture value through dependable composition, convenient formats and recurring brand orders, but claims about immunity, energy or disease outcomes require separate substantiation. The +0.8 pp contribution assumes 20% revenue exposure grows 4.0 percentage points faster through genuinely additional supplement participation and paid replenishment, excluding supplier switching and finished-supplement retail markups.
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Daily nutritional supplementation | +0.8 pp | US, Canada, Japan, Western Europe | Short term (≤ 2 years) |
| Conventional-food incorporation | +0.7 pp | Japan, US, EU, India | Short term (≤ 2 years) |
| Application-specific ingredient grades | +0.6 pp | Japan, US, EU manufacturing hubs | Short term (≤ 2 years) |
| Verified-source procurement | +0.6 pp | North America, EU, UK, Japan | Medium term (2–4 years) |
| Operating cultivation investment | +0.5 pp | US production; qualified export channels | Medium term (2–4 years) |
Restraint Analysis
Delivered-Protein Cost Disadvantage
Spirulina competes poorly in applications purchased primarily on cost per kilogram of delivered protein when its nutritional-biomass price exceeds that of established protein concentrates. FDA-hosted ingredient dossiers describe commercial spirulina biomass containing approximately 53–69% protein, depending on the supplier and specification; those composition figures do not establish its purchase price, digestibility-adjusted value or equivalence to an isolate.
In an illustrative procurement comparison, spirulina costing USD 12/kg at 60% protein supplies nominal protein at USD 20/kg, while a hypothetical alternative costing USD 4/kg at 80% protein supplies it at USD 5/kg.
Delivering 20 g protein therefore requires approximately 33.3 g spirulina costing USD 0.40, compared with 25 g of the alternative costing USD 0.10, before formulation, processing and verification. Across ten million servings, the assumed difference is USD 3 million. These prices are modeling inputs, not quoted 2026 market averages, and the comparison deliberately excludes any additional value assigned to spirulina’s other constituents. The immediate restraint arises when procurement teams reject spirulina for a cost-led protein application—not merely when growers experience higher operating costs.
Suppliers can target products that value multiple nutritional or formulation attributes, but that does not erase the disadvantage in commodity protein tenders. The −0.5 pp deduction assumes 25% revenue exposure grows 2.0 percentage points more slowly through rejected protein-replacement applications, excluding projects rejected primarily for taste, colour or serving-size limitations.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Delivered-protein cost disadvantage | −0.5 pp | US, Canada, EU, India | Short term (≤ 2 years) |
| Sensory-driven application rejection | −0.4 pp | North America, EU, Japan | Medium term (2–4 years) |
| Limited practical protein dosing | −0.3 pp | US, Canada, UK, EU | Medium term (2–4 years) |
| Ingredient-use eligibility gaps | −0.3 pp | US; US-bound ingredient suppliers | Medium term (2–4 years) |
| Unsupported therapeutic positioning | −0.2 pp | US supplement and food channels | Short term (≤ 2 years) |
Opportunity Analysis
Pigment-Reduced Protein Ingredients
Separating pigment-rich fractions from spirulina could make its remaining proteins usable in applications where whole biomass is rejected for colour, creating an addressable ingredient class rather than another micronized powder grade. An August 2026 review describes pigment removal as a fractionation problem with meaningful protein losses: phycocyanin represents approximately one-third of total protein in the cited biomass, leaving a theoretical maximum of roughly two-thirds of original protein after complete removal, before further recovery losses.
It also reports that high-pressure homogenization at 50 MPa increased solubility from approximately 65% to 91% in one investigated concentrate, but weak gelation remained; these are study-specific results, not a commercial ingredient specification.
In an illustrative process using 1,000 tonnes of biomass containing 60% protein, the initial protein pool is 600 tonnes. Removing one-third with the pigment fraction leaves approximately 400 tonnes; recovering 70% of that remainder yields 280 tonnes of nonpigmented protein, equivalent to 350 tonnes of ingredient at 80% purity. At an assumed USD 20/kg realization, gross eligible ingredient revenue is USD 7 million, excluding pigment revenue and subtracting any displaced biomass sales when measuring market expansion.
The opportunity depends on sensory performance, nutritional characterization, safe processing and use-specific regulatory eligibility—not simply removing visible colour. The +0.35 pp contribution assumes 7% revenue exposure grows 5.0 percentage points faster through newly qualified pigment-reduced applications; the coproduct opportunity below is allocated only to separate, already-operating pigment streams.
Opportunity Impact Analysis
| Opportunity | (~) % Potential CAGR Upside | Geographic Relevance | Execution Window |
|---|---|---|---|
| Pigment-reduced protein ingredients | +0.35 pp | US, EU, Japan food formulators | Medium term (2–4 years) |
| Food-grade coproduct recovery | +0.30 pp | US, Japan, China production hubs | Medium term (2–4 years) |
| Functional emulsion-gel systems | +0.30 pp | EU, UK, US alternative-protein hubs | Medium term (2–4 years) |
| Hydrolysate-based extrusion ingredients | +0.25 pp | US, Germany, Netherlands, Japan | Medium term (2–4 years) |
| Shared fractionation commercialization | +0.20 pp | EU, US, India ingredient clusters | Medium term (2–4 years) |
Challenges Analysis
Cultivation Productivity and Consistency
Spirulina cultivation requires continuous coordination of light, temperature, nutrient supply, mixing and culture condition, making stable output more difficult than extrapolating an optimal laboratory growth rate across a full production year. A June 2025 techno-economic review identifies cultivation-system selection and operating conditions as material determinants of biomass productivity and cost: open raceway ponds offer lower infrastructure costs but greater exposure to environmental variability and contamination, while controlled photobioreactors require additional capital and operating inputs.
In an illustrative operation with 100,000 m² of productive area, annual-average productivity of 15 g dry biomass/m²/day over 300 operating days produces 450 tonnes. A decline to 13 g/m²/day reduces output to 390 tonnes, a 60-tonne or 13.3% shortfall. At an assumed USD 12/kg ingredient realization, gross output-value exposure is USD 720,000; this becomes lost revenue only if inventory, alternative qualified supply or later production cannot recover customer orders.
If fixed operating expenditure remains USD 1.2 million, its allocation rises from USD 2.67/kg to USD 3.08/kg, approximately 15.4%, before variable inputs. Manufacturers need seasonal production budgets, culture-health surveillance, calibrated nutrient dosing and realistic harvest scheduling. The −0.30 pp contribution assumes 15% revenue exposure grows 2.0 percentage points more slowly through residual productivity variation and fixed-cost dilution, excluding rejected prices and the separate cost of contaminant testing.
Challenges Impact Analysis
| Challenge | (~) % CAGR Friction Drag | Geographic Relevance | Mitigation Horizon |
|---|---|---|---|
| Cultivation productivity and consistency | −0.30 pp | US, India, China, Thailand | Long term (≥ 4 years) |
| Contaminant prevention and verification | −0.30 pp | Global production; US, EU, Japanese buyers | Long term (≥ 4 years) |
| Dewatering and drying efficiency | −0.30 pp | US, India, China, EU processors | Medium term (2–4 years) |
| Extraction yield–functionality trade-offs | −0.30 pp | US, EU, Japan ingredient hubs | Medium term (2–4 years) |
| Lot-specific nutritional standardization | −0.20 pp | US, Canada, EU, UK, Japan | Medium term (2–4 years) |
Geopolitical Impact Analysis
Geopolitical Impact of Ongoing Wars on the Spirulina Protein Market
The ongoing conflicts in the Middle East and Russia-Ukraine region are creating indirect cost pressures on the global Spirulina Protein Market through energy price volatility, shipping disruptions and higher production expenses. Spirulina cultivation requires electricity, water circulation, harvesting, drying and processing equipment, making producers vulnerable to rising energy and transportation costs. Disruptions around the Strait of Hormuz have also affected international fertilizer and energy supplies, increasing uncertainty for industrial producers.
According to the World Bank’s October 2026 Commodity Markets Outlook, global energy prices are projected to increase by 32% in 2026, while fertilizer prices are expected to rise by 14%. These increases can raise operating expenses for spirulina cultivation facilities, particularly those dependent on energy-intensive drying and temperature-control systems.
The World Trade Organization also reported that urea prices increased from approximately USD 400 per metric tonne to more than USD 850 per metric tonne in April 2026 following the Gulf conflict. Although spirulina does not depend on conventional agricultural fertilizers to the same extent as field crops, higher energy, packaging and freight costs can affect its production economics. However, these disruptions may encourage manufacturers to invest in local cultivation, renewable energy and more efficient processing technologies to reduce dependence on international supply chains.
Regional Insights
Dominating Region: North America
In 2025, North America dominated the Spirulina Protein Market, accounting for 34.78% of the global market, valued at USD 0.2 billion. The region benefits from established dietary supplement industries, growing demand for plant-based nutrition and increasing use of algae-derived ingredients in functional foods and beverages. The United States remains an important contributor, supported by domestic spirulina cultivation facilities in California and Hawaii and a well-developed nutritional supplement distribution network.
According to the United States Food and Drug Administration (FDA), its regulatory framework covers spirulina-based food ingredients and dietary supplement products, supporting commercial development. Growing interest in natural ingredients and alternative protein sources continues to support regional demand.
Asia Pacific represents a strong growth opportunity for spirulina protein manufacturers, supported by its established algae cultivation industry, expanding food processing sector and increasing interest in alternative protein ingredients. The region benefits from a large aquaculture and animal nutrition industry, creating opportunities for spirulina-based feed formulations. According to the Food and Agriculture Organization (FAO), Asia accounted for 97% of global algae production in 2022, highlighting its strong production base and established algae supply chain. Investment in cultivation facilities, improved biomass processing and commercial algae applications is expected to support further development.
Key Regions and Countries Insights
- North America
- US
- Canada
- Europe
- Germany
- France
- The UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of MEA
Key Players Analysis
DIC Corporation is a leading participant in the spirulina industry through its subsidiary Earthrise Nutritionals. In March 2025, Earthrise started operations at a new algae cultivation facility in California following an investment of approximately JPY 1.2 billion. The facility covers approximately 420,000 square metres and produces around 550 tonnes of spirulina annually. It uses more than 1,200 tonnes of refined carbon dioxide annually, while over 50% of its energy requirements are met through renewable energy.
Cyanotech Corporation is an established producer of spirulina and microalgae-based nutritional ingredients. According to its fiscal year 2025 annual report, spirulina packaged sales reached USD 5.223 million, while bulk spirulina sales amounted to USD 2.405 million. Packaged sales declined by 9.6%, whereas bulk sales increased by 53% compared with fiscal year 2024. The company recorded total net sales of USD 24.215 million in fiscal 2025, reflecting its continued presence in the nutritional ingredient industry.
Parry Nutraceuticals, a division of E.I.D. Parry, focuses on organic spirulina and microalgae-based nutritional ingredients. The company has more than 42 years of experience in microalgae technology and exports its products to 41 countries. Its operations include organic spirulina cultivation, processing and nutritional supplement ingredients. The company reports 8 international quality certifications and more than 1,500 million doses delivered. Its product portfolio includes organic spirulina powder and tablets, supported by specialized cultivation and downstream processing technologies.
Top Key Players Outlook
- DIC Corporation
- Cyanotech Corporation
- Parry Nutraceuticals
- Earthrise Nutritionals
- Naturex
- Fuqing King Dnarmsa Spirulina
- Far East Bio-Tec
- Now Foods
- Other Key Players
Recent Developments
- In March 2025, Earthrise commenced operations at a new California cultivation facility following an investment of approximately USD 8 million (JPY 1.2 billion).
- In June 2026, Far East Bio-Tec Co., Ltd. approved the distribution of NT$1.5 per share as dividends, comprising NT$0.5 in cash and NT$1.0 in stock. For fiscal year 2025, the company reported consolidated revenue of NT$401.697 million, net income of NT$59.983 million and earnings per share of NT$1.89.
Report Scope
| Report Features | Description |
|---|---|
| Market Value (2025) | USD 0.8 Bn |
| Forecast Revenue (2035) | USD 1.4 Bn |
| CAGR (2026-2035) | 5.6% |
| Base Year for Estimation | 2025 |
| Historic Period | 2020-2024 |
| Forecast Period | 2026-2035 |
| Report Coverage | Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
| Segments Covered | By Form (Powder, Tablets & Capsules, Liquid, Others), By Application (Dietary Supplements, Animal Feed & Aquaculture, Pharmaceuticals, Cosmetics & Personal Care, Others)) |
| Regional Analysis | North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, Australia, Singapore, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – GCC, South Africa, Rest of MEA |
| Competitive Landscape | DIC Corporation, Cyanotech Corporation, Parry Nutraceuticals, Earthrise Nutritionals, Naturex, Fuqing King Dnarmsa Spirulina, Far East Bio-Tec, Now Foods, Other Key Players |
| Customization Scope | Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. |
| Purchase Options | We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) |


